Korea Fixed-Income Investment Management Acquires 12.53% Potential Stake in Hwail Pharm Via Convertible Bonds

• Korea Fixed-Income Investment Management disclosed a new 12.53% holding in Hwail Pharm through convertible bonds acquired October 8, 2026.
• The bonds represent 1,205,690 potential shares, held for investment purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hwail Pharm Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261102000162), on November 02, 2026, and is solely responsible for the information contained therein.